Form 4 for IMRX Immuneering Corp
Accepted 2024-03-25 00:00:00 ET · period of report 2024-03-22 · accession 0001790340-24-000042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-25 | 2024-03-22 | IMRX | Feinberg Peter | Dir | P - Purchase | $2.55 | +25.0K | 111.8K | +29% | +$63.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-03-22 | P | A | 25,000 | $2.55 | 111,766 | D | — | — | (F1) This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.52 to $2.57. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price. |